<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[IMS Health Inc. | Company News & Executive Profiles - RX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ims+health+inc..html?i=13]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for IMS Health Inc.]]></description>
	<s:counts start="0" returned="10" found="373" />
	<language>en-us</language>
	<item>
		<title><![CDATA[IMS Health Oversold on Senate Proposal]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F178222-ims-health-oversold-on-senate-proposal%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[IMS Health Inc. RX, the US healthcare information company which is in the process of being acquired for $22 a share by a PE consortium, saw its share price drop to $17.35 (-18%) before recovering to $20.05 (-6%) on Friday December 11, 2009.  The move was attributed to the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 15 Dec 2009 03:12:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/panta+capital.html"><![CDATA[Panta Capital]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[Drugmakers vow battle against House bill]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/drugmakers-vow-battle-house-bill/20502/]]></link>
		<description><![CDATA[With the U.S. House version of healthcare reform still moving forward, drugmakers are digging in. They're pledging to fight the House proposals it considers unfriendly to the industry, working closely with lobbyists and pushing back against sales projections that contradict industry talking points. AstraZeneca CEO David Brennan photo--who's also the...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Mon, 16 Nov 2009 08:47:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">DNA,RX</category>
	</item>
	<item>
		<title><![CDATA[IMS Health Merger Likely to Close]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173226-ims-health-merger-likely-to-close%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[On 05-Nov-09 IMS Health Inc RX, the US healthcare information company, announced it had signed an agreement to be acquired by TPG Capital and the Canada Pension Plan Investment Board for USD 22 cash a share. The agreement was unanimously approved by the IMS Board, and comes after IMS announced...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 13 Nov 2009 05:19:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/panta+capital.html"><![CDATA[Panta Capital]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[IMS Health Is Being Stolen from Shareholders]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F171626-ims-health-is-being-stolen-from-shareholders%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Vitaliy N. Katsenelson, CFA submits:  It was announced Thursday that IMS Health RX was to be stolen from its shareholders for $4 billion or about $22 share; a private equity firm will buy them out. IMS Health should have free cash flows this year of over $340 million (the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 05 Nov 2009 01:16:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vitaliy+katsenelson.html"><![CDATA[Vitaliy Katsenelson]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[IMS Health Inc., Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14061_23-355407.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.  Our first question comes from the line of Glen Santangelo - Credit Suisse. Glen Santangelo - Credit Suisse Dave, I just had a couple of quick questions; first, I saw no share repurchase again this quarter.  I watched the company for years...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 22 Oct 2009 11:09:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/restructuring.html"><![CDATA[Restructuring]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/restructuring+charge.html"><![CDATA[Restructuring Charge]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/credit+suisse+group+ag.html"><![CDATA[Credit Suisse Group AG]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[Pharma resilient during economic slog, says IMS Health]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/pharma-resilient-economic-slog-ims/15080/]]></link>
		<description><![CDATA[The global market for pharmaceuticals is expected to grow by 4%-6% in 2010 – exceeding $825 billion – due in part to near-term growth in the US, according to an IMS Health forecast.The forecast also predicts a 4%-7% growth over the next five years – a one percentage point increase...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 09 Oct 2009 02:31:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/growth.html"><![CDATA[growth]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/ibm+ims.html"><![CDATA[IBM IMS]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmacy.html"><![CDATA[Pharmacy]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[Top 15 bestselling drugs of 2008]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/15-bestselling-drugs-2008/10195/]]></link>
		<description><![CDATA[Ranking the best-selling branded drugs in the world is a bit like gathering the most popular kids in high school together in one room. The usual suspects are always there (in this case, that means Lipitor, Plavix, Seroquel, Effexor XR, et al.) until they graduate--or in this case, go off...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 02 Sep 2009 06:49:54 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/sales+figure.html"><![CDATA[sales figure]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[Is IMS Health a Good Investment?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F157201-is-ims-health-a-good-investment%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Matt Darrah submits: Below is our investment analysis for IMS Health RX. Executive Summary      Attractive and sustainable return on invested capital     Exceeded 100% over the past ten years     High customer switching costs should help sustain returns on...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 20 Aug 2009 01:06:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/matt+darrah.html"><![CDATA[Matt Darrah]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[IMS Health: Think Long Term]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F151384-ims-health-think-long-term%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Vitaliy N. Katsenelson, CFA submits:  IMS Health RX did not have a spectacular quarter, to put it mildly. Revenue decline on constant currency basis accelerated to 4% from a 2% decline last quarter. Pharmaceutical companies are becoming more stingy and thus RX&#8217;s business got pinched. However, most of the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 26 Jul 2009 04:28:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vitaliy+katsenelson.html"><![CDATA[Vitaliy Katsenelson]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[IMS Health Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F150863-ims-health-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[IMS Health RX   Q2 2009 Earnings Call   July 23, 2009 8:00 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 23 Jul 2009 09:53:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
</channel>
</rss>
